deep second degree burns. Burn of second degree, body region unspecified
Conditions
Interventions
Intervention 1: Control group: Fibrinolysin ointment (product of Vestagen Pars Company) is applied to a portion of the burn site and bandaged. Changing the dressing and examining the burn wound contin
Sponsors
Qazvin University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with deep second-degree burns who have been referred to the burn clinic of Shahid Rajaee Hospital in Qazvin. Burns of known depth and confirmed by a specialist (presence of a dry and thick, dark red or waxy white appearance) Burns in an area where it is possible to use two types of treatment (fibrinolysin ointment and ozone oil) simultaneously in two different parts. Written consent of the patient to participate in the study and acceptance of treatment conditions and periodic follow-ups
Exclusion criteria
Exclusion criteria: Patients with third-degree burns or very superficial burns (superficial second-degree or first-degree) Presence of active infection at the burn site at the time of study entry Patients with chronic skin diseases or chronic inflammatory disorders that can affect the healing process Previous use of fibrinolytic therapies or other specific treatments for burns at the study site Known sensitivity or allergy to any of the ingredients in fibrinolysin ointment or ozone oil Patients with severe systemic conditions or comorbidities that may affect burn healing (e.g., uncontrolled diabetes, renal or hepatic failure) Patient's inability or unwillingness to follow up on dressings and assess wounds regularly
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Burn treatment. Timepoint: Every other day for two weeks. Method of measurement: Changing the dressing and examining the burn wound by taking a picture of the wound and uploading it to the following site for color analysis: http://mkweb.bcgcsc.ca/color-summarizer/?analyze. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAmir Farzaneh
Qazvin University of Medical Sciences
Outcome results
None listed